Studies for which Dong et al15 sourced additional data from the FDA
| Outcome of interest | Study included in Dong et al15 | Availability of end point of interest | |
|---|---|---|---|
| Peer-reviewed publication | FDA | ||
| Overall mortality | Ambrosino et al24 | ✕ | ✓ |
| Cardiovascular mortality | Tashkin et al25 | ✕ | ✓ |
| Casaburi et al26 | ✕ | ✓ | |
| Brusasco et al27 | ✕ | ✓ | |
FDA, US Food and Drug Administration.